Curis
CRIS
#11033
Rank
A$8.77 M
Marketcap
A$1.31
Share price
6.65%
Change (1 day)
-34.81%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2023 (TTM): A-$15.06

According to Curis's latest financial reports the company's current EPS (TTM) is A-$20.61. In 2022 the company made an earnings per share (EPS) of A-$17.69 a decrease over its 2021 EPS that were of A-$14.50.

EPS history for Curis from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$15.06-14.82%
2022A-$17.6922%
2021A-$14.50-25.37%
2020A-$19.43-30.93%
2019A-$28.12-2.02%
2018A-$28.70-37.38%
2017A-$45.84-29.73%
2016A-$65.24-10%
2015A-$72.48138.1%
2014A-$30.4440%
2013A-$21.75-25%
2012A-$28.9966.67%
2011A-$17.40-850%
2010A$2.32-114.29%
2009A-$16.24-26.07%
2008A-$21.96-26.28%
2007A-$29.798.44%
2006A-$27.47-32.68%
2005A-$40.81-3.76%
2004A-$42.4062.95%
2003A-$26.02-93.86%
2002A-$423.6739.5%
2001A-$303.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.10-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.55-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.52-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$5.02-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.31-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$4.61-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$4.99-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA